Deferred Tax Assets, Valuation Allowance of Zomedica Corp. from 31 Dec 2016 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Zomedica Corp. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2016 to 31 Dec 2025.
  • Zomedica Corp. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $35,935,000, a 32% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Zomedica Corp. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $35,935,000 +$8,617,000 +32% 31 Dec 2025 10-K 16 Mar 2026 2025 FY
Q4 2024 $27,318,000 +$3,899,000 +17% 31 Dec 2024 10-K 16 Mar 2026 2025 FY
Q4 2023 $23,419,000 +$4,434,000 +23% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q4 2022 $18,985,000 +$2,787,000 +17% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q4 2021 $16,198,000 -$427,567 -2.6% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q4 2020 $16,625,567 +$3,224,497 +24% 31 Dec 2020 10-K 01 Mar 2022 2022 FY
Q4 2019 $13,401,070 +$4,453,160 +50% 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q4 2018 $8,947,910 +$5,604,720 +168% 31 Dec 2018 10-K 26 Feb 2020 2019 FY
Q4 2017 $3,343,190 +$1,349,430 +68% 31 Dec 2017 10-K/A 14 Mar 2019 2018 FY
Q4 2016 $1,993,760 31 Dec 2016 10-K 28 Feb 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.